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Abstract
Progress in the somatosensory field has been restricted by the limited number of genetic tools available to study
gene function in peripheral sensory neurons. Here we generated a Cre-driver mouse line that expresses Cre-
recombinase from the locus of the sensory neuron specific gene Advillin. These mice displayed almost exclusive
Cre-mediated recombination in all peripheral sensory neurons. As such, the Advillin-Cre-driver line will be a
powerful tool for targeting peripheral neurons in future investigations.
Background
The identification of new molecular targets and
mechanisms in the peripheral nervous system is an on-
going challenge in the field of somatosensation. Our
understanding of this system has often been limited by
the ubiquitous expression of many sensory neuron
genes and an inability to target these genes specifically
in peripheral sensory neurons.
Knockout mice are the tools of choice for studying
mammalian gene function, but perinatal lethality and
developmental compensation are commonly occurring
problems that can complicate interpretation of results.
These can be avoided by creating tissue- or develop-
mentally specific knockout mice by means of the Cre-
loxP system, where specific Cre-recombinase driver
mice are crossed with mice containing loxP-flanked
(’floxed’) genes of interest [1,2].
Several Cre mouse lines are av a i l a b l et h a tt a r g e ts u b -
populations of neurons in the peripheral sensory system,
in particular nociceptive neurons. These include mice
where Cre is under control of the locus of the voltage-
gated sodium channel Nav1.8 (expression in most noci-
ceptors but not in mechanoreceptive neurons) [3-6], or
of the Peripherin gene, a marker for small sensory neu-
rons [7]. Similarly, many Cre-driver mouse lines are
available for targeting neuronal subpopulations in the
central nervous system. However, to date it has not
been possible to generate Cre drivers to target all sub-
populations of peripheral sensory neurons without
affecting other tissues in the organism. Hence, the exis-
tence of Cre mouse lines with specificity for the periph-
eral nervous system (PNS) would allow a much more
detailed investigation of the molecular mechanisms and
function of primary sensory neurons.
Advillin is an actin regulatory/binding protein of the
gelsolin/villin family with a role in neuronal outgrowth
and stress response in peripheral sensory neurons
[8-11]. The initial gene-expression study of Advillin by
Northern blot analyses and in situ hybridization revealed
that it is found in uterus, testis, taste buds, and also at
low levels in the brain [12]. Strong expression was
found in dorsal root ganglia (DRG) and trigeminal gang-
lia (TG) at embryonic stages E14.5 to E16.5 and in the
adult animal. Hasegawa and colleagues [9] created an
alkaline phosphatase knock-in mouse line of the Advillin
gene locus (Avil-hPLAP mice) in order to perform histo-
logical analyses. They found Advillin expression almost
exclusively in peripheral sensory neurons during devel-
opment and adulthood and observed strong staining in
DRG, TG, vestibulocochlear ganglia, plossophayrngeal
ganglia, and vagus ganglia. In line with this finding, the
expression of Pervin, which is the rat homologue of the
mouse Advillin protein, is restricted to DRG neurons
and superior cervical ganglia neurons [8,10,13]. Hence,
Advillin appears to be a promising candidate for the
generation of a Cre-driver mouse line with specificity in
the PNS ganglia.
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BAC-transgenic animals expressing Cre-recombinase
under the regulatory elements of the Advillin gene. We
present the pattern of specific Cre-mediated recombina-
tion by means of b-galactosidase staining after crossing
with lacZ reporter mice containing a LoxP-flanked
STOP-cassette upstream of a LacZ expression cassette
[14]. Furthermore, we investigate acute pain behavior in
these mice. Our data indicate that this mouse line is a
valuable tool to specifically target and investigate sen-
sory neurons in dorsal root ganglia and trigeminal
ganglia.
Results
Generation of Advillin-Cre transgenic mice and copy
number analysis
We chose a bacterial artificial chromosome (BAC) of the
RP23 library (RP23-109K12) that contains a total of 175
kb, and thereof 168 kb of upstream putative regulatory
sequence to the Advillin gene. The BAC clone was veri-
fied and modified by lambda RedET-recombination
(homologous recombination in Escherichia coli) to incor-
porate a cassette containing the SV40 T nuclear localiza-
tion signal, the Cre-gene, and the SV40 large T antigen
polyA signal (Figure 1A) [15,16]. The homology arms
necessary for homologous recombination were intro-
duced to the cassette as described in Materials and
Methods, and the NLS-Cre-pA cassette was inserted into
e x o n2o ft h eAdvillin locus, thereby substituting the
endogenous ATG of Advillin with the NLS-Cre coding
sequence (Figure 1A). The outcome of recombineering
was screened by restriction digest and PCR, and after
obtaining successfully modified clonal colonies, integrity
of the introduced cassette was verified by full length
sequencing. Afterwards, the DNA of the Advillin-Cre
modified BAC was isolated, purified, and either microin-
jected into the pronucleus of oocytes from B6D2F1/N
mice (Charles River Laboratories) or prepared for intra-
cytoplasmic sperm injection (ICSI), where the DNA is
injected together with membrane-damaged sperm cells
into non-fertilized metaphase II oocytes [17,18]. Both
applications successfully produced transgenic Advillin-
Cre animals.
There is a strong correlation between increased copy
number integration and increased transgene expression
in independent transgenic lines [19,20]. BAC transgenic
mice generally do not contain more than 1-5 copies,
although rarely, some transgenic animals with more
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Figure 1 Generation of Advillin-Cre transgenic mice. A. Schematic representation of ET-recombination based insertion of a NLS-Cre gene
cassette into the coding region of a BAC containing the mouse Advillin gene locus. The cassette was recombined into the locus immediately
after the start codon of exon 2. After purification, the final 177 kb construct was injected into the pronucleus or used for intracytoplasmic sperm
injection. HA: homology arms for recombination; NLS: SV-40-T nuclear localization signal; Cre: Cre gene; V5: V5 epitope tag; PA: SV-40
polyadenylation signal; EM7-KAN: kanamycin cassette under a prokaryotic EM7 promoter. B. Copy number analysis by means of LightCycler PCR
revealed that Advillin-Cre mice have five copies per genome.
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Page 2 of 10copies have been achieved [19,21-23]. To determine the
situation in our generated animals, we compared a sam-
ple of unknown copy number from our Advillin-Cre
mouse genomic DNA to a range of DNA copy number
standards. We spiked in varying amounts of purified
BAC DNA into wildtype mouse genomic DNA and by
means of LightCycler qPCR amplification cycle values
were plotted to generate a standard curve to estimate
the copy number from our Advillin-Cre mice. Thereby,
we calculated that our described Advillin-Cre line has
five copies of the transgene per genome (Figure 1B).
Cre is expressed in peripheral sensory tissues in adult
Advillin-Cre mice
We mated heterozygous male Advillin-Cre
tg/+ mice with
homozygous female Rosa26-lacZ
tg/tg reporter (R26R)
mice [14] (Jackson Laboratories, Bar Harbor, ME) in
order to characterize the expression pattern of func-
tional Cre. The reporter mice carry a stop cassette
flanked by loxP sites preceding the gene for b-galactosi-
dase. The latter will be selectively expressed in the pre-
sence of active Cre recombina s et h a te x c i s e st h ef l o x e d
polyadenylation site. In addition, we crossed male Advil-
lin-Cre
tg/+ mice with a novel, as yet unpublished,
Rosa26-CFP reporter mouse strain.
We collected adult tissues from the progeny in order
to screen for Cre recombinase expression and Cre
+/+-lacZ
tg/+ littermates were used as a negative control.
The expression of functional Cre was investigated by
staining for b-galactosidase (lacZ activity) using X-gal as
described previously [14]. X-gal was detected in whole-
mount tissues, such as the midbrain (Figure 2A and
2C), brainstem (Figure 2A and 2D), tongue (Figure 2J
and 2K), vestibular ganglia (Figure 2G), trigeminal gang-
lia (Figure 2E), dorsal root ganglia (Figure 2H), superior
cervical ganglia (SCG) (Figure 2N), and nodose ganglia
(not shown). Figure 2B, F, and 2L depict brain, trigem-
inal ganglia, and tongue, respectively, from control ani-
mals. We did not observe any Advillin expression in
olfactory or visual ganglia, other CNS regions or non-
neuronal tissues. Thus, spinal cord (Figure 2I), liver
(Figure 2O), skin (Figure 2M), thymus, testes, heart, and
ovaries (not shown) were Cre negative. Intestines were
excluded from the study due to endogenous b-galactosi-
dase expression in Cre negative reporter mice.
A more detailed analysis by sectioning tissues (20 μm),
that showed X-gal staining previously, revealed that the
pattern of b-galactosidase expression was similar in tri-
geminal and dorsal root ganglia in Advillin-Cre
tg/
+/lacZ
tg/tg mice (Figure 3D and 3A, respectively). Most
importantly, almost all neurons in these ganglia were
stained.
We quantified DRG sections by staining the tissue of
Advillin-Cre
tg/+/CFP reporter mice. After double
staining with anti-NeuN and anti-GFP antibodies, six
sections were counted. 82.28% (743/903) of NeuN-posi-
tive cells (Figure 3K), and thus neuronal cells, were also
positive for CFP (Figure 3L), and thus Cre expressing.
Moreover, 87.74% (673/767) of neurons from six DRG
sections of Advillin-Cre
tg/+/lacZ
tg/tg mice, counted by
their characteristic shape, were also positively stained
for X-gal (Figure 3M).
Midbrain sections showed the ventral tegmental area
(VTA) to be b-galactosidase positive (Figure 3H). In the
tongue, the circumvallate and foliate papillae, which are
both innervated by the glossopharyngeal nerve,
expressed functional Cre (Figure 3B and 3C), while the
fungiform papillae were X-gal-negative. Sagittal (Figure
3E, F, and 3G) and coronal (Figure 3I) sections of the
brainstem were also taken and X-gal staining demon-
strated some Cre activity. Sensory brainstem nuclei
expressed Advillin sparsely (Figure 3E and 3I), such as
the spinal (Figure 3E arrow, Figure 3F arrow, and I) and
medial vestibular nucleus (Figure 3E and 3G star, Figure
3I), the nucleus of solitary tract (Figure 3I), the spinal
nucleus of the trigeminal nerve (Figure 3I), and the
medial trigeminal nucleus (Figure 3E and 3G arrowhead,
Figure 3I).
In conclusion, Advillin is expressed mainly in periph-
eral sensory ganglia, with additional expression in
selected cells of the taste buds, vestibular ganglia and
second-order nuclei, as well as the ventral tegmental
area of the midbrain.
Cre expression during development
T i m e dm a t i n g sw e r es e tu pb e t w e e nh e t e r o z y g o u s
male Advillin-Cre
tg/+ mice and homozygous female
Rosa26-lacZ
tg/tg reporter (R26R) mice [14] (Jackson
Laboratories, Bar Harbor, ME). Females were sacri-
ficed in accordance of animal welfare procedures to
collect embryos at stages E12.5, E16.5, and E18.5. Cre
+/+/lacZ
tg/+ embryo littermates were used as negative
control. Cre expression was not detectable in any tis-
sues at E12.5 (not shown), but trigeminal ganglia
showed lacZ activity at E16.5 (Figure 4A) and E18.5
(not shown). We detected some endogenous b-galac-
tosidase staining in the bone marrow of Advillin-Cre
expressing animals (Figure 4C, E18.5), which was also
observed in embryos from the control background.
DRGs did not express Advillin at any embryonic stage
(see Figure 4B for X-gal staining at stage E18.5).
Therefore, we cut DRG sections from perinatal Cre
tg/
+/lacZ
tg/+ mice (P1) and demonstrated positive X-gal
staining (Figure 4D). The vestibular ganglion
expressed b-galactosidase at embryonic stage E18.5
(Figure 4C), while the remaining central nervous sys-
tem and tissues were Advillin-Cre negative during
development.
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Page 3 of 10Advillin-Cre mice show normal mechanical and heat
nociceptive behavior
Litters (average n = 5-6) appeared healthy and had nor-
mal gross motor and sensory function, as assessed by
the SHIRPA test [24]. By means of the hot plate test, we
investigated acute thermal nociceptive thresholds (Figure
5A). The mean reaction time was comparable between
Advillin-Cre mice (9.84 sec, n = 5) and their wildtype
littermates (8.63 sec, n = 6). There was no significant
difference between the two groups (p = 0.151) when
compared using an unpaired t-test. In addition to ther-
mal nociception, we assessed the sensitivity to
Figure 2 X-gal staining in whole-mount tissues from adult mice. Cre mediated recombination was detected in adult Advillin-Cre mice
crossed with R26R mice for lacZ expression. Organs were collected and stained with X-gal. Representative pictures are shown. A. brain from Cre
expressing mice and B. Cre negative animals. C. close up of midbrain region of A. D. brainstem. E. and F. trigeminal ganglia from Advillin-Cre
mice and littermate controls, respectively. G. vestibular ganglion. H. DRG. I. unstained spinal cord with a stained DRG. J. circumvallate taste buds
in the tongue. K. foliate taste buds in the tongue. L. tongue from control mice. X-gal negative M. skin N. superior cervical ganglia, and O. liver
from Cre expressing mice. CRE: Advillin-Cre mice. CTR: wildtype littermates controls. Scale bar: 1 mm.
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Page 4 of 10Figure 3 X-gal staining in tissue sections from adult mice. Cryo-sections from adult tissue after staining with X-gal, NeuN, or GFP. A. DRG. B.
circumvallate taste buds in the tongue. C. foliate taste buds in the tongue. D. trigeminal ganglion. E. sagittal brainstem section. F. close up of
caudal brainstem with staining in spinal tract of trigeminal nerve and spinal nucleus of trigeminal nerve (arrow). G. close up of rostral brainstem
region with some staining in the medial trigeminal nucleus (arrowhead) and medial vestibular nucleus (star). H. Midbrain section with diffuse
staining in the ventral tegmental area. I. coronal brainstem section with staining in secondary sensory ganglia. J. SCG section. K. and L. DRG
sections with NeuN staining (red) and GFP staining (green) for quantification. M. DRG section with X-gal staining illustrating the quantification
procedure. Scale bar: A. and D. 10 micrometer. B., C., F., G., J., K., L., and M. 100 micrometer. E., H., and I. 1 mm.
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dynamic plantar test [25]. There was no significant dif-
ference in the mean paw withdrawal latency between
Advillin-Cre mice and wildtype littermates (9.24 sec and
10.18 sec, respectively; p = 0.66) (Figure 5B). In addition,
the mean force applied to induce a withdrawal response
did not show significant differences between the two
groups (Advillin-Cre: 3.5 g; wildtype littermates: 3.99 g;
p = 0.122) (Figure 5C).
Discussion
Based upon previous expression studies demonstrating
that Advillin is expressed in a somatosensory-specific
manner [8,9], we generated a BAC transgenic Cre-driver
mouse line that expresses Cre-recombinase from the
Advillin locus. We characterized this line by means of
copy number analysis, X-gal staining and pain behavior.
We found that Advillin is highly expressed in sensory
ganglia such as TG and DRG, with sparser expression in
vestibular ganglia, superior cervical ganglia, nodose
ganglia, taste buds, secondary sensory nuclei in the
brainstem, and the VTA in the midbrain. Finally, acute
nociceptive responses to thermal and mechanical stimuli
were detected to be normal.
Transgenic mice generated using BAC technology are
widely used in biology to study gene function. BACs are
excellent tools for maintaining large DNA fragments
and are extensively used to generate transgenic Cre
recombinase driver lines [26,27]. BAC-based transgenes
have the advantage of usually directing gene expression
at physiological levels with the same developmental tim-
ing and expression patterns as endogenous genes [28].
Generation thereof is less time consuming than embryo-
nic stem (ES) cell mediated transgenesis by knock-in,
with comparable end results [29]. With this in mind we
chose to use a BAC transgenic-based approach to gener-
ate our Advillin-Cre transgenic mouse line. Of note, a
Cre driver line has been described that utilized a knock-
in strategy into the Advillin locus [30]. As yet, there is
no reported characterization of the developmental or
adult expression profile of Cre in these mice, nor any
behavioral analysis to the best of our knowledge.
BAC transgenes usually contain sufficient regulatory
information to recapitulate endogenous gene expression
patterns [31], and the optimal transgene drives expres-
sion in a cell-specific, copy-dependent fashion [19,20].
Usually one to five BAC transgene concatemers inte-
grate into a single locus of the genome [20,21,32] and
an increased BAC transgene copy number correlates
with increased BAC transgene expression [19,20]. How-
ever, rare cases have been reported, in which more than
five copies were integrated [22,23]. Our copy number
estimates are based on a standard curve of known BAC
copy number standards, which is a useful means to con-
firm transgene expression and stable integration. Quan-
tification by qPCR revealed that our Advillin-Cre mice
carry five copies of the transgenes in their genomes.
Based on a hallmark publication, copy numbers usually
remain fixed in subsequent generations and among lit-
termates [19].
We assessed the expression of the Cre gene in the
Advillin locus using X-gal staining after breeding with
R26R mice and a CFP reporter line. Functional Cre
could be found in more than 82% of all neurons of
these ganglia indicating that it was expressed by both,
mechanoreceptors and nociceptors. The remaining
Advillin-negative expressing neurons were not further
characterized. However, secondary neurons of dorsal
root afferents in the dorsal horn of the spinal cord were
Advillin-negative, indicating that this Cre-line targets
only the peripheral part of the somatosensory pathway.
Figure 4 X-gal staining for lacZ activity at embryonic stages
and P1. Sections from embryos expressing Advillin-Cre and lacZ
during different stages. A. trigeminal ganglia at E16.5. B. unstained
DRG and traces of endogenous b-galactosidase at E18.5. C.
vestibular ganglion at E18.5. D. perinatal (P1) stained DRG section.
Scale bar: 1 mm.
Figure 5 Mechano- and heat nociceptive behaviour. A. Reaction
time in seconds of Advillin-Cre mice and their wildtype littermates
during the hotplate test (p = 0.151). B. Latency to paw withdrawal
in seconds during the dynamic plantar test (p = 0.699). C. Force
applied at moment of paw withdrawal during the dynamic plantar
test (p = 0.122). Data are expressed in mean ± SEM.
Zurborg et al. Molecular Pain 2011, 7:66
http://www.molecularpain.com/content/7/1/66
Page 6 of 10We were not able to detect Advillin-Cre expression in
DRG at embryonic stages, while X-gal staining was
clearly detectable in neonatal mice at P1. In previous
studies, Advillin expression has been reported starting at
embryonic stage E12.5 with peak expression between
E14.5 and E16.5 [9,12]. Consistent with our negative
spinal cord staining, expression of Advillin in the spinal
cord has not been reported previously.
The trigeminal ganglion, which contains primary sen-
sory neurons innervating the face, projects to trigeminal
sensory nuclei (principal trigeminal nucleus and spinal
trigeminal nucleus) in the brainstem (reviewed by [33]).
We found X-gal staining also in these second-order
neurons, however in adult mice only.
Although TG progenitors are generated at early devel-
opmental stages (E8.25 - E9) in the mouse, and brain-
stem nuclei progenitor cells are formed by stage E15.5
[33], we detected X-gal staining for functional Cre in tri-
geminal ganglia at embryonic stage E16.5 and E18.5 but
not at E12.5. Advillin expression has been described at
these earlier stages [9,12] and Hasegawa and colleagues
[9] found scattered Advillin expression in TG at stage
E11.5. In line with our study, they also reported adult
Advillin expression in higher-order trigeminal nuclei [9].
In agreement with previous reports, we observed Advil-
lin mediated Cre expression in the vestibular ganglion of
adult mice [9]. In addition, we detected functional Cre
expression in second-order brainstem neurons, and in
the medial and spinal vestibular nuclei of adult mice.
Moreover, during development, we observed Advillin
expression in the vestibular ganglion at E18.5. Positive X-
gal staining also occurred in taste buds of both the cir-
cumvallate and foliate papilla, which has been previously
reported [12]. However, taste buds in the fungiform
papillae, which are not innervated by the glossopharyn-
geal nerve but by the greater superficial petrosal nerve
[34], were Cre negative. As for the TG and vestibular
nuclei, we detected staining in second-order neurons of
the gustatory pathway, in the nucleus of the solitary tract
of the brainstem [34]. At embryonic stages, we did not
detect any staining in these areas. The only other brain
region where we found positive (albeit sparse) staining in
adults was the ventral tegmental area (VTA) of the mid-
brain. This region contains mainly dopaminergic neurons
and functions in the reward circuitry of the brain. From
here, neurons project to numerous areas of the brain,
such as the prefrontal cortex [35]. Besides the above-
mentioned regions, other tissues and brain areas did not
express functional Cre in our Advillin-Cre animals. In
summary, Advillin is expressed in several sensory ganglia
w h e r ei ti sf o u n di np r i m a r ya n ds o m es e c o n d a r yn e u -
rons. Advillin-Cre mice may therefore be useful driver
lines for gene targeting in other sensory areas in addition
to the somatosensory system.
To rule out a putative affect on nociceptive behavior
response caused by expression of Cre in primary sensory
neuron populations, we obtained data from paradigms
testing thermal and mechanical nociceptive thresholds
(hot plate test, dynamic plantar test) [36,37]. Responses
to these stimuli were similar in Advillin-Cre mice and
their wildtype littermates (Figure 5A). In addition, trans-
genic animals had normal overall gross motor and sen-
sory function, assessed by the SHIRPA test [24]. Thus
our data indicate that expression of Cre from the Advil-
lin locus does not alter baseline behavioral responses.
Taken together, this is the first report of a sensory
neuron specific Cre driver line with expression covering
both mechanoreceptive and nociceptive neurons.
Furthermore the late developmental onset of Cre
expression will be advantageous in avoiding develop-
mental defects and lethality associated with some genes.
Advillin-Cre mice have been deposited at the EMMA
mouse repository.
Conclusions
Expression of Cre recombinase from the Advillin locus
is apparent in almost all peripheral sensory neurons of
the DRG and TG. In addition, Cre-recombination is also
evident in some vestibular and gustatory neurons and in
second order neurons of the brainstem. Thus, Advillin
Cre mice are an important addition to the genetic tool-
box for conditional gene ablation studies in sensory
biology.
Materials and methods
Generation of transgenic construct and ET recombination
A 175-kb bacterial artificial chromosome (BAC) con-
taining the mouse Advillin locus (RP23-109K12) was
obtained from a C57BL/6J BAC library (Children’sH o s -
pital Oakland Research Institute). Individual BAC clones
were thoroughly characterized and subsequently trans-
formed with a plasmid conferring competence for
lambda RedET mediated recombineering. A cassette
containing the SV40-large T antigen nuclear localization
signal, the Cre cDNA, a V5 epitope tag (Invitrogen), a
SV40 T polyadenylation site, and a selectable marker (a
kanamycin cassette under the prokaryotic em7 promo-
ter) was assembled in a pBSSK
+ backbone. Insertion of
the NLS-Cre-V5-pA cassette into the BAC backbone
was performed using RedET recombineering as pre-
viously described [15,16], and targeted clones were
selected for growth on Kanamycin. Clonal isolates were
re-streaked twice and clonal identity was confirmed by
PCR, restriction-digestion and full length sequencing of
the inserted cassette. Purified BAC DNA was dissolved
into Endotoxin-free TE and injected into pronuclei
derived from the hybrid B6D2F1/N strain (Charles River
Laboratories) or prepared for intracytoplasmic sperm
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methods were successful and produced offspring. Mice
progeny were analyzed for BAC insertion by genomic
PCR amplification with the following primer: 5’gcact-
gatttcgaccaggtt3’ and 5’gagtcatccttagcgccgta3’.
Copy number analysis
Real-time PCR (LightCycler
® 480 SYBR Green I Master
kit, Roche Applied Science) with Cre genotype primers
was used to estimate the BAC transgene copy number
in BAC transgenic lines. Advillin-Cre BAC cDNA was
spiked into WT genomic DNA at 1, 2, 4, 8, 16, and 32
copies per genome. A standard curve was calculated
from the crossing points of spiked DNA and compared
to results of Advillin-Cre mouse genomic DNA.
X-gal staining for b-galactosidase (lacZ) activity
Animals and tissue preparation
Heterozygous male Advillin-Cre
tg/+ mice were mated
with the homozygous female Rosa26-lacZ
tg/tg (R26R)
reporter mouse strain [14] (Jackson Laboratories, Bar
Harbor, ME). Embryos were collected at E12.5, E16.5,
and E18.5 for developmental analysis. Additionally, neo-
natal (postnatal day 1, P1) mice and tissues from adult
mice were investigated. Mouse embryos and adult tis-
sues were dissected in the presence of PBS containing
0 . 9m MC a C l 2 and 0.5 mM MgCl2. After genotyping for
a double expression of Advillin-Cre and lacZ,e m b r y o s
and adult tissues were stained for b-galactosidase
expression (whole-mount or cryostat sections of 20 μm).
X-gal staining
Tissues and sections were stained with X-gal for lacZ
activity as described in [38,39]. Briefly, after dissection
embryos, tissues and sections were rinsed in phosphate
buffer (0.1 M sodium phosphate monobasic, 0.1 M
sodium phosphate dibasic, pH 7.3) for 10 minutes. They
were fixed in 4% formaldehyde dissolved in ddH20f o r
10-30 minutes at room temperature and rinsed three
times for 30 minutes in wash buffer (2 mM MgCl2,
0.01% deoxycholate, 0.02% Nonidet-P40, and 100 mM
NaPO4, pH 7.3). Tissue and sections were stained for 2
hours or overnight at 37°C in wash buffer containing 1
mg/ml X-gal, 6 mM potassium ferrocyanide, and 5 mM
potassium ferricyanide.
Quantification of Advillin-Cre expression
We crossed male Advillin-Cre
tg/+ mice with a CFP repor-
ter mouse strain. DRG were frozen in tissue embedding
compound (OCT) directly after isolation. 12 μmt h i c k
sections were cut with a cryostat and dried at room tem-
perature for 10 min. Afterwards, sections were postfixed
in cold 4% formaldehyde on ice for 5 min and washed 10
min in PBS on ice. Standard immunefluorescence proto-
cols were applied for the staining with chicken anti-GFP
(1:500 concentration, Aves Labs, GFP-1020) and mouse
anti-NeuN (1:100 concentration, Millipore MAB377).
Sections were background corrected by comparison to
control sections only labeled with secondary antibodies
and counted for NeuN and GFP staining.
Imaging of stained tissue and sections
Whole-mount tissue images were taken with a stereomi-
croscope (MacroFluo Leica Z16A, CCD camera CD500).
Mosaic images of sections were taken with a motorized
widefield microscope (Leica DMRXA, high resolution
colored CCD camera DC300F).
Behavioral assessment of nociception
Animals
Five to six heterozygous male transgenic Advillin-Cre
tg/+
animals and their wild-type littermates were used at age
two to three months. Animals were housed in groups of
3-4 per cage with food and water ad libitum at 22-24°C
on 12-hour light-dark cycle. All mice were acclimated
for at least 1 week prior to testing. All tests were carried
out between 13:30 and 15:30 where mice were habitu-
ated 30 minutes prior to the testing room. All proce-
dures were approved by the Italian Ministry of Health
and the EMBL Animal Ethics Committee.
Modified SHIRPA Test
The modified SHIRPA is a primary screening based on
observational assessment [24]. It is a basic behavioral
battery that includes measures of muscle, cerebellar,
sensory, and autonomic functions. It allows detecting
overt, serious dysfunctions in the mouse before further
behavioral phenotyping takes place.
Thermal Nociception
Pain sensitivity to thermal stimulus was tested using the
hot plate test [37]. We recorded the hind-paw withdra-
wal latency to heat stimulation using a Hot Plate appa-
ratus (Ugo Basile, Varese, Italy). Briefly, mice were
individually placed on a hot plate with the temperature
adjusted to 55 ± 1°C. The time to the first sign of noci-
ception was recorded and the animal was immediately
r e m o v e df r o mt h eh o tp l a t e .Ac u t - o f fp e r i o do f6 0s e c -
onds was maintained to avoid damage to the tissue.
Hind-paw response was scored from videotape as either
a foot lifting (jump) or a foot shake or a paw lick
[36,40]. Each mouse was used once only.
Mechanical Nociception
Mechanical allodynia was assessed using a Dynamic
Plantar Anesthesiometer (Ugo Basile, Italy) by measur-
ing the latency to withdraw the hind paw from a graded
f o r c ea p p l i e dt ot h ep l a n t a rs u r f a c eu s i n gav o nF r e y
filament.
The electronic von Frey device applied a single non-
flexible filament (0.5 mm in diameter) with increasing
force (0.1 g/s; from 0 to 5 g, [25]) against the plantar
surface over a 10-second- period. The paw withdrawal
Zurborg et al. Molecular Pain 2011, 7:66
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Page 8 of 10response automatically turned off the stimulus, and the
pressure eliciting the response was recorded. For mea-
surements, mice were placed individually into red enclo-
sures on a framed metal mesh floor and allowed to
acclimate for 10 minutes before testing. Paw withdrawal
thresholds were measured in triplicate for each paw of
each animal, allowing at least 30 second intervals
between successive measurements. In case of no with-
drawal up to 5 grams this maximum force is maintained
until the paw is withdrawn. The paw withdrawal thresh-
old is numerically obtained in grams (force applied) and
in seconds (latency of withdrawal).
Data and statistics
All data are presented as mean ± SEM. Unpaired t-tests
were applied and p < 0.05 was considered statistically
significant.
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